The National Cancer Institute is committed to dramatically lessening the impact of cancer.
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer.
The SBIR & STTR Programs are one of the largest sources of early-stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities and a new spirit of collaboration with the NCI.
The NCI SBIR Development Center is interested in learning more about how SBIR & STTR funding is helping your company to achieve its cancer research goals and business objectives. Please click here to fill out a 'Share Your Story' form, and let us know about any developments with your NCI SBIR- or STTR-funded projects. Learn more about how other successful NCI SBIR & STTR companies are using their funding awards to advance cancer research.
Learn about Funding & Resources Available from the NCI SBIR & STTR Programs
In an article published in Nature Biotechnology, SBIR & STTR Development Center staff discuss the application process and provide tips for applying for funding through the SBIR & STTR Programs.
The 2015 NCI SBIR & STTR Omnibus Solicitation has been issued:
Receipt dates: September 8, 2015; January 5, 2015; April 5, 2016
NIH is changing its Standard Due Dates for SBIR & STTR grant applications.
The policy for late submissions has been updated. Review the Guide Notice to learn more.
2015 Receipt date: September 8
Download slides from a webinar about the I-Corps™ at NIH pilot program, which seeks to accelerate development and commercialization of new SBIR/STTR-funded products and services.
Learn how the new NIH Resubmission Policy affects SBIR and STTR applications. Effective April 17, 2014